Heat-activated liposome encapsulated doxorubicin (ThermoDox) for hepatocellular carcinoma – first line

Source:
Centre for Reviews and Dissemination Health Technology Assessments - CRD HTA
Publisher:
Centre for Reviews and Dissemination
Publication date:
06 July 2012

Abstract

Bibliographic details

NHSC.  Heat-activated liposome encapsulated doxorubicin (ThermoDox) for hepatocellular carcinoma - first line. Birmingham: National Horizon Scanning Centre (NHSC). Horizon Scanning Review. 2011

Status

This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.

Indexing status

Subject indexing assigned by CRD

Index terms

Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Doxorubicin; Humans